While preclinical studies and anecdotal evidence suggest potential benefits, the lack of comprehensive clinical trial data limits our understanding of its full therapeutic potential and possible side effects
the peptide has been shown to promote the healing of tendons, ligaments, muscles, nerves, bones, teeth, corneas, and the endothelium, the lining of blood vessels
And many grey market peptide consumers, particularly those who source their peptides directly from compounding pharmacies overseas, dont believe the approval of these peptides will do much of anything to stem the grey market, especially because peptides purchased from overseas labs, often in China, are astronomically cheaper
Additionally, it has been shown to mitigate the adverse effects of corticosteroids on tendon-to-bone healing [12]
Does this product page provide dosing or human-use guidance
As of this spring there is still no randomized trial of BPC-157 in humans for any condition